Skip to content

Written by Sarah Collins · Every article cited · Reviewed on a schedule

How we source
PCOSguides
All topics

1000 articles planned across 8 sections. Each one carries a minimum of three primary sources.

Hirsutism and PCOS: Why It Happens and What Actually Reduces It

8 min read

Written by Sarah CollinsChecked against the 2023 International Evidence-Based Guideline for the Assessment and Management of PCOSLast reviewed Published

A registered dietitian and clinician review is being arranged for this site. Until this article carries a named reviewer, treat it as a well-sourced summary of published guidance — not as a substitute for advice about your own case.

The short answer

Hirsutism — coarse, dark hair on the face, chest or back — is caused by androgens acting on hair follicles, and PCOS and idiopathic hyperandrogenism together account for more than 85% of cases in women of reproductive age. Hormonal treatments only stop new hairs forming and take at least six months. Eflornithine cream and hair removal work on hair that already exists.

What causes hirsutism in women?

Most people simply call this facial hair, or excess facial hair — hirsutism is the clinical term, and the same hormonal (androgen) mechanism drives it wherever on the body it appears.

A hair follicle does not know it is growing “excess” hair. It is responding to a signal.

Androgens — mainly testosterone and its more potent skin metabolite, dihydrotestosterone (DHT) — bind receptors in the follicle and convert soft, unpigmented vellus hair into thick, pigmented terminal hair, in the same pattern typically seen in male body-hair distribution: upper lip, chin, chest, lower abdomen, inner thighs. The follicle’s sensitivity to androgens, not just the amount of androgen circulating, decides how visible the change is — which is why two women with identical testosterone levels can have very different amounts of hair.

Polycystic ovary syndrome and idiopathic hyperandrogenism together cause more than 85% of hirsutism cases in women of reproductive age, per a 2019 clinical review in American Family Physician. Rarer causes — androgen-secreting tumours, congenital adrenal hyperplasia, Cushing’s syndrome — need ruling out when hair growth is sudden, rapid, or comes with a deepening voice or clitoral enlargement.

Note: in May 2026, PCOS was renamed polyendocrine metabolic ovarian syndrome, or PMOS, by a global consensus of more than 50 organisations. Same condition, same androgen mechanism behind hirsutism — only the label on the diagnosis changed. This article uses PCOS, since that is still the term most readers search. Hirsutism is one of four PMOS symptom groups — see PMOS symptoms for the full picture.

How is hirsutism actually measured?

A modified Ferriman-Gallwey score of 8 or higher defines hirsutism in Black and white women assessed in the US and UK, but that threshold is not universal. The Endocrine Society’s clinical practice guideline recommends adjusting the cutoff by population — lower thresholds are appropriate in East Asian women, who grow visibly less terminal hair at the same androgen level, and higher baseline growth is normal in some women of Mediterranean and Middle Eastern descent. Population-specific cutoffs exist for other groups too, and there’s no single number that covers everyone — which is exactly why it’s worth asking a clinician which reference population your score was actually read against, rather than assuming one universal threshold applies. A clinician scoring nine body sites against photographic standards, not a mirror check at home, is the only way to get a number that means anything.

What treatments actually reduce hirsutism?

Every effective option falls into one of two categories: medications that slow down what the follicle produces, or direct methods that physically remove what is already there. Nothing in the first category works before a full hair growth cycle has passed.

Table 1 — hirsutism treatment options, how they work, and when to expect a visible change.
OptionHow it worksTime to see change
Combined oral contraceptiveSuppresses ovarian androgen production, raises SHBG so less testosterone is free6+ months minimum
Anti-androgen (e.g. spironolactone)Blocks the androgen receptor at the follicle; added if the pill alone is not enough6+ months, added after a 6-month pill trial
Eflornithine creamInhibits an enzyme (ODC) the follicle needs to build the hair shaft; facial use only4–8 weeks for initial change, continues improving to 24 weeks
Laser or electrolysisDamages the follicle directly with heat or electrical currentImmediate per session; several sessions needed for lasting reduction

The 2023 international PCOS guideline recommends a combined oral contraceptive as first-line pharmacologic treatment, with an anti-androgen added after roughly six months if the response is inadequate — never as a starting point alone, since anti-androgens carry a feminisation risk to a male fetus and need reliable contraception alongside them. Direct hair removal is recommended as an adjunct at any point, because it is the only option that changes what you see this week rather than in six months.

Each option comes with practical trade-offs worth knowing before you start:

  • Combined oral contraceptive. Contraindicated with uncontrolled high blood pressure, a history of blood clots, migraine with aura, or smoking over 35. Also treats the irregular cycles most PCOS phenotypes have alongside hirsutism.
  • Spironolactone. Requires a baseline and follow-up potassium check, especially alongside ACE inhibitors, ARBs, NSAIDs, or potassium supplements — each raises the same hyperkalaemia risk together. Significant kidney impairment and Addison’s disease are separate reasons it’s avoided, since both already push potassium up on their own. Not safe in pregnancy, which is the practical reason it is paired with contraception rather than prescribed alone. Whether it also affects weight is a separate, often-asked question, distinct from the hirsutism dosing and monitoring covered here.
  • Eflornithine cream. Mild stinging, burning or acne-like breakouts at the application site are the most common side effects, reported more often than with the vehicle cream alone in trials. It hasn’t been established as safe in pregnancy, so it’s worth mentioning to whoever is prescribing if you are pregnant, trying to conceive, or breastfeeding.
  • Laser. Works best when there is strong contrast between dark hair and light skin. A long-pulsed Nd:YAG laser is the safer choice for darker skin tones; the wrong wavelength can burn or scar. Electrolysis works on any hair or skin colour, including grey and blonde hair laser cannot target, but treats one follicle at a time.

Does eflornithine cream actually treat facial hirsutism?

Eflornithine cream is the one topical option with FDA approval specifically for facial hirsutism, and it is the treatment most likely to show a change inside two months.

In two identical 24-week randomised, double-blind trials of women with facial hirsutism, treatment success — a physician rating of “clear/almost clear” or “marked improvement” — was reached by 24.4% and 44% of women using eflornithine cream in the two trials, compared with 4.3% and 13% on the vehicle cream alone. Both differences were statistically significant. Effects reversed within about eight weeks of stopping the cream, because it manages hair growth rather than the androgen signal driving it.

Two things worth unlearning first

Shaving does not make hair grow back thicker, darker, or faster. A razor cuts the shaft, not the follicle, and the blunt tip left behind only feels coarser until it grows past the skin’s surface again. The follicle’s output is set by the androgen signal reaching it, not by whether you shaved last week.

Plucking and waxing pull the whole hair, root included, so regrowth takes longer than shaving. But repeated plucking in the same follicle over years can trigger local inflammation and, in some people, scarring or a compensatory increase in nearby follicle activity — a reasonable trade to make for a wedding, a poor one to run for a decade on the same patch of skin.

If your hirsutism runs with insulin resistance

Hyperinsulinemia pushes ovarian theca cells to make more androgen and lowers the liver’s output of SHBG, the protein that keeps testosterone bound and inactive. Less SHBG means more free testosterone reaching the follicle — one route among several that link insulin resistance to visible PCOS symptoms.

That does not mean an insulin-sensitising drug is a hirsutism treatment. Metformin’s effect on hirsutism specifically is weak and inconsistent across trials — useful for the metabolic picture, not a substitute for the pill, an anti-androgen, or direct hair removal when hirsutism itself is the problem you are treating. If your pattern is insulin-resistant, expect metformin to help other things sooner than it helps your chin.

When this needs a doctor sooner rather than later

Hirsutism that develops gradually over years, alongside irregular cycles, fits the ordinary PCOS picture and can be worked through with your GP or a gynaecologist.

Elevated androgens also show up as other visible signs worth checking together, and facial hair specifically has its own management details covered in chin and jawline hair.

Common questions

  • What counts as mild hirsutism, or mild PCOS facial hair?

    There's no separate diagnostic cutoff for "mild." The guidelines behind this page define only one threshold — a modified Ferriman-Gallwey score of 8 or higher for hirsutism itself — so "mild" is an informal description clinicians use for scores sitting just above that line, with more extensive or denser terminal hair described as moderate or severe. The label doesn't change what's recommended: the same first-line options apply whether your score is just over the cutoff or well past it.
  • What medications treat hirsutism?

    A combined oral contraceptive is first-line, lowering ovarian androgen production and raising SHBG so less testosterone reaches the follicle. An anti-androgen such as spironolactone is added afterward if that alone isn't enough, always alongside reliable contraception since it isn't safe in pregnancy. Eflornithine cream is a medication too, though a topical one — it slows the hair shaft itself rather than the androgen signal behind it, which is why it can show a change within two months instead of six. None of these cure hirsutism; each works only for as long as you keep using it.

Your next step

Book a Ferriman-Gallwey assessment with your GP or gynaecologist before starting anything, so you have a real baseline number to measure against in six months. Guidelines support running a hormonal option and a direct-removal method together, rather than waiting to see if the first one works alone — ask a clinician which hormonal option fits your history and what it’s contraindicated with before starting. How hirsutism fits alongside the rest of what PCOS does to the body, symptom by symptom, is worth reading if you’re still mapping your own pattern.

More on this

Sources

  1. 1.Matheson E, Bain J. Hirsutism in Women. American Family Physician. 2019.
  2. 2.Martin KA, Anderson RR, Chang RJ, et al. Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018.
  3. 3.Teede HJ, Tay CT, Laven JJE, et al. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023.
  4. 4.Wolf JE Jr, Shander D, Huber F, et al. Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair. Int J Dermatol. 2007.
  5. 5.Teede HJ, Khomami MB, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026.

Find your PCOS type

Loading the questions…